Trial Finds Patients Receiving CroFab® Antivenom Less Likely to Use Opioids for Pain Control
PHILADELPHIA–(BUSINESS WIRE)–BTG plc (LSE: BTG), the global healthcare company, today announced the publication of a trial, “Antivenom Treatment is Associated…